This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Portsmouth Merger Sub Ii, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Michel Streuli: Innovator in Antibody Development
Introduction
Michel Streuli is a prominent inventor based in Atherton, California. He has made significant contributions to the field of immunology through his innovative work on antibodies. With a total of two patents to his name, Streuli is recognized for his advancements in treatments for immune-related conditions.
Latest Patents
Streuli's latest patents include "Anti-TREM2 antibodies and related methods." This patent provides methods for making and using anti-TREM2 antibodies, which are crucial for enhancing immune responses and treating conditions such as cancer. Another notable patent is "Anti-MARCO antibodies and uses thereof," which outlines methods for generating and utilizing anti-MARCO antibodies.
Career Highlights
Streuli is currently associated with Portsmouth Merger Sub II, LLC, where he continues to push the boundaries of antibody research. His work has the potential to impact various therapeutic areas, particularly in enhancing immune responses.
Collaborations
Throughout his career, Streuli has collaborated with notable professionals in the field, including Venkataraman Sriram and Leonard G. Presta. These collaborations have further enriched his research and development efforts.
Conclusion
Michel Streuli's contributions to antibody development are noteworthy and reflect his commitment to advancing medical science. His innovative patents and collaborations position him as a key figure in the field of immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile